Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154307 · ClinicalTrials.gov registry record · NA
Repeated TMS at Low Frequencies to Reduce Seizure Occurrence
A NA study, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03154307 is a NA study that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 2 participants.
The verdict
NCT03154307, a NA study, was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Perform non-invasive neuro-navigated repeated Transcranial Magnetic Stimulation (rTMS) at low frequencies (LF) with the intent to reduce the occurrence of seizures over time (long-term protocol). Seizure reduction and improvements in the quality of life in patients with epilepsy will be associated with increased cortical inhibition resulting from the LF-rTMS sessions over time. This procedure using rTMS at low frequencies (LF-rTMS) between 0.5 and 1 Hz is a safe and painless method for noninvasive focal cortical brain stimulation, which will be evaluated in its efficacy at reducing/suppressing seizures. Accordingly, we propose a clinical trial in patients with epilepsy to test whether LF-rTMS can improve seizure suppression. The location of the presumed 3D source in the brain will be stimulated for few minutes (10 to 15 min.). With the same rTMS modality, we will also perform motor threshold mapping in conjunction with its fully integrated and compatible electroencephalography (EEG) module. Up to 100 individuals 18 to 80 years with epilepsy will be enrolled. In addition, a short-term protocol has been added to test whether LF-rTMS can reduce or suppress status epilepticus in medically refractory participants.
Interventions
- DEVICE Low frequency repeated TMS (LF-rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-02-19 |
| Est. Completion | 2019-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154307
The ClinicalTrials.gov registry entry for NCT03154307 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low frequency repeated TMS (LF-rTMS) is the first listed.
NCT03154307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03154307 about?
NCT03154307 is a clinical study titled "Repeated TMS at Low Frequencies to Reduce Seizure Occurrence". Perform non-invasive neuro-navigated repeated Transcranial Magnetic Stimulation (rTMS) at low frequencies (LF) with the intent to reduce the occurrence of seizures over time (long-term protocol). Seizure reduction and improvements in the quality of life in patients with epilepsy will be associated w...
What is the current status of trial NCT03154307?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-02-19. Estimated completion is 2019-08-23.
What interventions are being tested in trial NCT03154307?
The interventions under investigation include: Low frequency repeated TMS (LF-rTMS) (DEVICE).
Who is sponsoring clinical trial NCT03154307?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.